HopeStage
Back to all studies
CompletedNCT00129272

Bupropion with or without behavioral support for young smokers

About this title

Effectiveness of Bupropion for Treating Nicotine Dependence in Young People

Read the official source — NCT00129272
Medication studyAges 12–25United StatesAddiction
The study in practice

Understand this study

Who was this study for?

Listed age limits: 12 years to 25 years.

Listed locations
DallasSee all locations and recruitment
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateMay 2004
Recruitment status
Completed
Enrollment listed in the registry
172
Sponsor
National Institute on Drug Abuse (NIDA)
Sponsor type
Research institute
Study type
Drug
Intervention type
Drug, Other
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Locations
United States
Age range
From 12 Years to 25 Years
Official registry ID
NCT00129272
Official title
Show the full official title

Stress Response and Smoking Cessation in Depressed Youth

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Dallas

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is National Institute on Drug Abuse (NIDA), a research institute.

Did this study involve medication?

Yes. The study involved medication, including Bupropion-SR.

Who was this study for?

Listed age limits: 12 years to 25 years.

Want to explore more studies?

Explore studies